A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth
Ruicci, Kara M., Meens, Jalna, Sun, Ren X., Rizzo, Giananthony, Pinto, Nicole, Yoo, John, Fung, Kevin, MacNeil, Danielle, Mymryk, Joe S., Barrett, John W., Boutros, Paul C., Ailles, Laurie, Nichols, ALanguage:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.32009
Date:
November, 2018
File:
PDF, 1.54 MB
english, 2018